PRJNA375882: Comprehensive Mouse Transcriptomic BodyMap
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Hey1
|
ENSMUSG00000040289.9 | Hey1 |
Myc
|
ENSMUSG00000022346.18 | Myc |
Mxi1
|
ENSMUSG00000025025.15 | Mxi1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Mxi1 | mm39_v1_chr19_+_53317844_53317911 | -0.66 | 4.3e-10 | Click! |
Hey1 | mm39_v1_chr3_-_8732316_8732353 | -0.43 | 1.7e-04 | Click! |
Myc | mm39_v1_chr15_+_61857390_61857471 | 0.15 | 2.0e-01 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr10_+_126899396 | 14.61 |
ENSMUST00000006911.12
|
Cdk4
|
cyclin-dependent kinase 4 |
chr10_+_126899468 | 11.80 |
ENSMUST00000120226.8
ENSMUST00000133115.8 |
Cdk4
|
cyclin-dependent kinase 4 |
chr9_+_107464841 | 11.21 |
ENSMUST00000010192.11
|
Ifrd2
|
interferon-related developmental regulator 2 |
chr7_+_34818709 | 9.21 |
ENSMUST00000205391.2
ENSMUST00000042985.11 |
Cebpa
|
CCAAT/enhancer binding protein (C/EBP), alpha |
chr8_-_41586713 | 8.36 |
ENSMUST00000155055.2
ENSMUST00000059115.13 ENSMUST00000145860.2 |
Mtus1
|
mitochondrial tumor suppressor 1 |
chr14_-_30740946 | 7.77 |
ENSMUST00000228341.2
|
Gnl3
|
guanine nucleotide binding protein-like 3 (nucleolar) |
chr4_+_133280680 | 7.51 |
ENSMUST00000042706.3
|
Nr0b2
|
nuclear receptor subfamily 0, group B, member 2 |
chr3_-_75864195 | 7.46 |
ENSMUST00000038563.14
ENSMUST00000167078.8 ENSMUST00000117242.8 |
Golim4
|
golgi integral membrane protein 4 |
chr5_+_119808722 | 7.44 |
ENSMUST00000079719.11
|
Tbx3
|
T-box 3 |
chr9_-_43151179 | 7.26 |
ENSMUST00000034512.7
|
Oaf
|
out at first homolog |
chr19_+_46561801 | 7.02 |
ENSMUST00000026011.8
|
Sfxn2
|
sideroflexin 2 |
chr15_-_67048595 | 6.91 |
ENSMUST00000229213.2
|
St3gal1
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 1 |
chr11_-_93846453 | 6.91 |
ENSMUST00000072566.5
|
Nme2
|
NME/NM23 nucleoside diphosphate kinase 2 |
chr8_+_41315419 | 6.80 |
ENSMUST00000098816.10
ENSMUST00000057784.15 |
Slc7a2
|
solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 |
chr1_+_55127110 | 6.62 |
ENSMUST00000075242.7
|
Hspe1
|
heat shock protein 1 (chaperonin 10) |
chr5_+_77099229 | 6.50 |
ENSMUST00000141687.2
|
Paics
|
phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoribosylaminoimidazole, succinocarboxamide synthetase |
chr2_+_121279842 | 6.38 |
ENSMUST00000110615.8
ENSMUST00000099475.12 |
Serf2
|
small EDRK-rich factor 2 |
chr17_-_45906428 | 6.23 |
ENSMUST00000171081.8
ENSMUST00000172301.8 ENSMUST00000167332.8 ENSMUST00000170488.8 ENSMUST00000167195.8 ENSMUST00000064889.13 ENSMUST00000051574.13 ENSMUST00000164217.8 |
Slc29a1
|
solute carrier family 29 (nucleoside transporters), member 1 |
chr10_+_43355113 | 6.21 |
ENSMUST00000040147.8
|
Bend3
|
BEN domain containing 3 |
chr11_-_51891259 | 6.19 |
ENSMUST00000020657.13
|
Ube2b
|
ubiquitin-conjugating enzyme E2B |
chr1_-_55127183 | 6.17 |
ENSMUST00000027123.15
|
Hspd1
|
heat shock protein 1 (chaperonin) |
chr15_-_67048673 | 6.11 |
ENSMUST00000229028.2
|
St3gal1
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 1 |
chr11_+_74540284 | 6.10 |
ENSMUST00000117818.2
ENSMUST00000092915.12 |
Cluh
|
clustered mitochondria (cluA/CLU1) homolog |
chr8_+_35842872 | 6.05 |
ENSMUST00000210337.2
ENSMUST00000070481.8 ENSMUST00000211648.2 |
Ppp1r3b
|
protein phosphatase 1, regulatory subunit 3B |
chr2_+_31360219 | 6.02 |
ENSMUST00000102840.5
|
Ass1
|
argininosuccinate synthetase 1 |
chr9_-_35028100 | 5.99 |
ENSMUST00000034537.8
|
St3gal4
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 4 |
chr14_-_30741012 | 5.89 |
ENSMUST00000037739.8
|
Gnl3
|
guanine nucleotide binding protein-like 3 (nucleolar) |
chr5_-_137312424 | 5.82 |
ENSMUST00000199121.2
|
Trip6
|
thyroid hormone receptor interactor 6 |
chr14_-_70588803 | 5.75 |
ENSMUST00000143153.2
ENSMUST00000127000.2 ENSMUST00000068044.14 ENSMUST00000022688.10 |
Slc39a14
|
solute carrier family 39 (zinc transporter), member 14 |
chr5_-_22549688 | 5.74 |
ENSMUST00000062372.14
ENSMUST00000161356.8 |
Reln
|
reelin |
chr7_-_68398917 | 5.71 |
ENSMUST00000118110.3
|
Arrdc4
|
arrestin domain containing 4 |
chr19_+_6952319 | 5.71 |
ENSMUST00000070850.8
|
Ppp1r14b
|
protein phosphatase 1, regulatory inhibitor subunit 14B |
chr10_+_22034460 | 5.69 |
ENSMUST00000181645.8
ENSMUST00000105522.9 |
Raet1e
H60b
|
retinoic acid early transcript 1E histocompatibility 60b |
chr7_-_98010478 | 5.59 |
ENSMUST00000094161.11
ENSMUST00000164726.8 ENSMUST00000206414.2 ENSMUST00000167405.3 |
Tsku
|
tsukushi, small leucine rich proteoglycan |
chr2_+_28730418 | 5.49 |
ENSMUST00000113853.3
|
Ddx31
|
DEAD/H box helicase 31 |
chr19_+_46045675 | 5.49 |
ENSMUST00000126127.8
ENSMUST00000147640.2 |
Pprc1
|
peroxisome proliferative activated receptor, gamma, coactivator-related 1 |
chr5_-_77099406 | 5.47 |
ENSMUST00000140076.2
|
Ppat
|
phosphoribosyl pyrophosphate amidotransferase |
chr1_-_75156993 | 5.45 |
ENSMUST00000027396.15
|
Abcb6
|
ATP-binding cassette, sub-family B (MDR/TAP), member 6 |
chr19_+_4560500 | 5.44 |
ENSMUST00000068004.13
ENSMUST00000224726.3 |
Pcx
|
pyruvate carboxylase |
chr11_-_51891575 | 5.37 |
ENSMUST00000109086.8
|
Ube2b
|
ubiquitin-conjugating enzyme E2B |
chr7_-_68398989 | 5.34 |
ENSMUST00000048068.15
|
Arrdc4
|
arrestin domain containing 4 |
chr7_-_25358406 | 5.34 |
ENSMUST00000071329.8
|
Bckdha
|
branched chain ketoacid dehydrogenase E1, alpha polypeptide |
chr2_+_84670956 | 5.31 |
ENSMUST00000111625.2
|
Slc43a1
|
solute carrier family 43, member 1 |
chr5_+_77099154 | 5.27 |
ENSMUST00000031160.16
ENSMUST00000120912.8 ENSMUST00000117536.8 |
Paics
|
phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoribosylaminoimidazole, succinocarboxamide synthetase |
chr11_+_117700479 | 5.20 |
ENSMUST00000026649.14
ENSMUST00000177131.8 ENSMUST00000120928.2 ENSMUST00000175737.2 ENSMUST00000132298.2 |
Syngr2
Gm20708
|
synaptogyrin 2 predicted gene 20708 |
chr9_+_108216466 | 5.15 |
ENSMUST00000193987.2
|
Gpx1
|
glutathione peroxidase 1 |
chr1_-_120192977 | 5.14 |
ENSMUST00000140490.8
ENSMUST00000112640.8 |
Steap3
|
STEAP family member 3 |
chr14_-_20231871 | 5.07 |
ENSMUST00000024011.10
|
Kcnk5
|
potassium channel, subfamily K, member 5 |
chr2_+_84669739 | 5.05 |
ENSMUST00000146816.8
ENSMUST00000028469.14 |
Slc43a1
|
solute carrier family 43, member 1 |
chr3_-_129126362 | 5.03 |
ENSMUST00000029658.14
|
Enpep
|
glutamyl aminopeptidase |
chr7_-_98010534 | 5.02 |
ENSMUST00000165257.8
|
Tsku
|
tsukushi, small leucine rich proteoglycan |
chrX_-_161612373 | 4.98 |
ENSMUST00000041370.11
ENSMUST00000112316.9 ENSMUST00000112315.2 |
Txlng
|
taxilin gamma |
chr2_+_130116357 | 4.98 |
ENSMUST00000136621.9
ENSMUST00000141872.2 |
Nop56
|
NOP56 ribonucleoprotein |
chr9_+_108216433 | 4.96 |
ENSMUST00000191997.2
|
Gpx1
|
glutathione peroxidase 1 |
chr10_+_43354807 | 4.94 |
ENSMUST00000167488.9
|
Bend3
|
BEN domain containing 3 |
chr11_-_54924231 | 4.83 |
ENSMUST00000108883.10
ENSMUST00000102727.3 |
Anxa6
|
annexin A6 |
chr6_+_17463748 | 4.82 |
ENSMUST00000115443.8
|
Met
|
met proto-oncogene |
chr2_+_74498551 | 4.80 |
ENSMUST00000001872.5
|
Hoxd13
|
homeobox D13 |
chr4_+_20007938 | 4.79 |
ENSMUST00000125799.8
ENSMUST00000121491.8 |
Ttpa
|
tocopherol (alpha) transfer protein |
chr9_+_46179899 | 4.79 |
ENSMUST00000121598.8
|
Apoa5
|
apolipoprotein A-V |
chr17_-_25179635 | 4.72 |
ENSMUST00000024981.9
|
Jpt2
|
Jupiter microtubule associated homolog 2 |
chr11_+_114742619 | 4.70 |
ENSMUST00000053361.12
ENSMUST00000021071.14 ENSMUST00000136785.2 |
Gprc5c
|
G protein-coupled receptor, family C, group 5, member C |
chr4_+_141473983 | 4.69 |
ENSMUST00000038161.5
|
Agmat
|
agmatine ureohydrolase (agmatinase) |
chr4_+_148675939 | 4.69 |
ENSMUST00000006611.9
|
Srm
|
spermidine synthase |
chr11_-_88609048 | 4.66 |
ENSMUST00000107909.8
|
Msi2
|
musashi RNA-binding protein 2 |
chr1_-_86286690 | 4.61 |
ENSMUST00000185785.2
|
Ncl
|
nucleolin |
chr2_+_84670543 | 4.59 |
ENSMUST00000111624.8
|
Slc43a1
|
solute carrier family 43, member 1 |
chr7_-_100661181 | 4.59 |
ENSMUST00000178340.3
ENSMUST00000037540.5 |
P2ry2
|
purinergic receptor P2Y, G-protein coupled 2 |
chr17_-_27158514 | 4.55 |
ENSMUST00000114935.9
ENSMUST00000025027.10 |
Cuta
|
cutA divalent cation tolerance homolog |
chr11_-_94492688 | 4.44 |
ENSMUST00000103164.4
|
Acsf2
|
acyl-CoA synthetase family member 2 |
chr11_-_59937302 | 4.39 |
ENSMUST00000000310.14
ENSMUST00000102693.9 ENSMUST00000148512.2 |
Pemt
|
phosphatidylethanolamine N-methyltransferase |
chr9_+_77824646 | 4.38 |
ENSMUST00000034904.14
|
Elovl5
|
ELOVL family member 5, elongation of long chain fatty acids (yeast) |
chr5_+_31079177 | 4.37 |
ENSMUST00000031053.15
ENSMUST00000202752.2 |
Khk
|
ketohexokinase |
chr6_+_90439596 | 4.36 |
ENSMUST00000203039.3
|
Klf15
|
Kruppel-like factor 15 |
chr18_+_56840813 | 4.32 |
ENSMUST00000025486.9
|
Lmnb1
|
lamin B1 |
chr11_-_93859064 | 4.30 |
ENSMUST00000107844.3
ENSMUST00000170303.2 |
Nme1
Gm20390
|
NME/NM23 nucleoside diphosphate kinase 1 predicted gene 20390 |
chr9_+_40712562 | 4.30 |
ENSMUST00000117557.8
|
Hspa8
|
heat shock protein 8 |
chr5_+_114268425 | 4.26 |
ENSMUST00000031587.13
|
Ung
|
uracil DNA glycosylase |
chr10_-_4338032 | 4.25 |
ENSMUST00000100078.10
|
Zbtb2
|
zinc finger and BTB domain containing 2 |
chr2_-_32584132 | 4.25 |
ENSMUST00000028148.11
|
Fpgs
|
folylpolyglutamyl synthetase |
chrX_-_72965524 | 4.24 |
ENSMUST00000114389.10
|
Naa10
|
N(alpha)-acetyltransferase 10, NatA catalytic subunit |
chr17_-_87573294 | 4.21 |
ENSMUST00000145895.8
ENSMUST00000129616.8 ENSMUST00000155904.2 ENSMUST00000151155.8 ENSMUST00000144236.9 ENSMUST00000024963.11 |
Mcfd2
|
multiple coagulation factor deficiency 2 |
chr3_-_101195213 | 4.20 |
ENSMUST00000029456.5
|
Cd2
|
CD2 antigen |
chr10_+_61484331 | 4.19 |
ENSMUST00000020286.7
|
Ppa1
|
pyrophosphatase (inorganic) 1 |
chr6_+_90439544 | 4.18 |
ENSMUST00000032174.12
|
Klf15
|
Kruppel-like factor 15 |
chr11_-_88608958 | 4.14 |
ENSMUST00000107908.2
|
Msi2
|
musashi RNA-binding protein 2 |
chr11_-_60702081 | 4.13 |
ENSMUST00000018744.15
|
Shmt1
|
serine hydroxymethyltransferase 1 (soluble) |
chr5_+_28370687 | 4.13 |
ENSMUST00000036177.9
|
En2
|
engrailed 2 |
chr15_+_99615396 | 4.12 |
ENSMUST00000023760.13
ENSMUST00000162194.2 |
Gpd1
|
glycerol-3-phosphate dehydrogenase 1 (soluble) |
chr17_+_57556449 | 4.07 |
ENSMUST00000224947.2
ENSMUST00000019631.11 ENSMUST00000224885.2 ENSMUST00000224152.2 |
Trip10
|
thyroid hormone receptor interactor 10 |
chr1_+_130754413 | 4.05 |
ENSMUST00000027675.14
ENSMUST00000133792.8 |
Pigr
|
polymeric immunoglobulin receptor |
chr7_-_48530777 | 3.97 |
ENSMUST00000058745.15
|
E2f8
|
E2F transcription factor 8 |
chr11_+_70735572 | 3.97 |
ENSMUST00000076270.13
ENSMUST00000179114.8 ENSMUST00000100928.11 |
Rabep1
|
rabaptin, RAB GTPase binding effector protein 1 |
chrX_-_133442596 | 3.95 |
ENSMUST00000054213.5
|
Timm8a1
|
translocase of inner mitochondrial membrane 8A1 |
chr6_-_136638926 | 3.91 |
ENSMUST00000032336.7
|
Plbd1
|
phospholipase B domain containing 1 |
chr11_-_100830288 | 3.88 |
ENSMUST00000138438.2
|
Stat3
|
signal transducer and activator of transcription 3 |
chr2_+_164611812 | 3.83 |
ENSMUST00000088248.13
ENSMUST00000001439.7 |
Ube2c
|
ubiquitin-conjugating enzyme E2C |
chr7_+_46495256 | 3.82 |
ENSMUST00000048209.16
ENSMUST00000210815.2 ENSMUST00000125862.8 ENSMUST00000210968.2 ENSMUST00000092621.12 ENSMUST00000210467.2 |
Ldha
|
lactate dehydrogenase A |
chrX_-_72965434 | 3.79 |
ENSMUST00000096316.4
ENSMUST00000114390.8 ENSMUST00000114391.10 ENSMUST00000114387.8 |
Naa10
|
N(alpha)-acetyltransferase 10, NatA catalytic subunit |
chr1_+_172328768 | 3.76 |
ENSMUST00000111228.2
|
Tagln2
|
transgelin 2 |
chr5_+_119808890 | 3.76 |
ENSMUST00000121021.8
|
Tbx3
|
T-box 3 |
chr2_-_11506511 | 3.76 |
ENSMUST00000183869.8
|
Pfkfb3
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 |
chr11_-_53313950 | 3.74 |
ENSMUST00000036045.6
|
Leap2
|
liver-expressed antimicrobial peptide 2 |
chr11_+_95557783 | 3.73 |
ENSMUST00000125172.8
ENSMUST00000036374.6 |
Phb
|
prohibitin |
chr5_+_45650821 | 3.72 |
ENSMUST00000198534.2
|
Lap3
|
leucine aminopeptidase 3 |
chr13_+_73911797 | 3.65 |
ENSMUST00000017900.9
|
Slc12a7
|
solute carrier family 12, member 7 |
chr10_+_44144346 | 3.64 |
ENSMUST00000039286.5
|
Atg5
|
autophagy related 5 |
chr11_+_84070593 | 3.64 |
ENSMUST00000137500.9
ENSMUST00000130012.9 |
Acaca
|
acetyl-Coenzyme A carboxylase alpha |
chr2_+_122065230 | 3.63 |
ENSMUST00000110551.4
|
Sord
|
sorbitol dehydrogenase |
chr11_-_100830366 | 3.61 |
ENSMUST00000127638.8
|
Stat3
|
signal transducer and activator of transcription 3 |
chr11_-_69563133 | 3.61 |
ENSMUST00000163666.3
|
Eif4a1
|
eukaryotic translation initiation factor 4A1 |
chr8_+_13209141 | 3.61 |
ENSMUST00000033824.8
|
Lamp1
|
lysosomal-associated membrane protein 1 |
chr11_+_84070678 | 3.61 |
ENSMUST00000136463.9
|
Acaca
|
acetyl-Coenzyme A carboxylase alpha |
chr5_+_45650716 | 3.61 |
ENSMUST00000046122.11
|
Lap3
|
leucine aminopeptidase 3 |
chr11_+_70735751 | 3.59 |
ENSMUST00000177731.8
ENSMUST00000108533.10 ENSMUST00000081362.13 ENSMUST00000178245.2 |
Rabep1
|
rabaptin, RAB GTPase binding effector protein 1 |
chr4_-_43523595 | 3.58 |
ENSMUST00000107914.10
|
Tpm2
|
tropomyosin 2, beta |
chr16_+_20491465 | 3.57 |
ENSMUST00000044783.14
ENSMUST00000115463.8 ENSMUST00000142344.8 ENSMUST00000073840.12 ENSMUST00000143939.8 ENSMUST00000128594.8 ENSMUST00000150333.8 ENSMUST00000231618.2 ENSMUST00000140576.8 ENSMUST00000115457.8 |
Eif4g1
|
eukaryotic translation initiation factor 4, gamma 1 |
chr19_+_29078765 | 3.56 |
ENSMUST00000064393.6
ENSMUST00000235900.2 |
Rcl1
|
RNA terminal phosphate cyclase-like 1 |
chr4_-_129472328 | 3.56 |
ENSMUST00000052835.9
|
Fam167b
|
family with sequence similarity 167, member B |
chr6_-_52203146 | 3.56 |
ENSMUST00000114425.3
|
Hoxa9
|
homeobox A9 |
chr7_-_100661220 | 3.53 |
ENSMUST00000207916.2
|
P2ry2
|
purinergic receptor P2Y, G-protein coupled 2 |
chr1_+_172327812 | 3.53 |
ENSMUST00000192460.2
|
Tagln2
|
transgelin 2 |
chrX_-_154121454 | 3.51 |
ENSMUST00000026328.11
|
Prdx4
|
peroxiredoxin 4 |
chr11_-_100830183 | 3.51 |
ENSMUST00000092671.12
ENSMUST00000103114.8 |
Stat3
|
signal transducer and activator of transcription 3 |
chr1_-_180083859 | 3.50 |
ENSMUST00000111108.10
|
Psen2
|
presenilin 2 |
chr11_-_51647290 | 3.48 |
ENSMUST00000109097.9
|
Sec24a
|
Sec24 related gene family, member A (S. cerevisiae) |
chr2_-_27317004 | 3.46 |
ENSMUST00000056176.8
|
Vav2
|
vav 2 oncogene |
chr7_+_141056305 | 3.46 |
ENSMUST00000117634.2
|
Tspan4
|
tetraspanin 4 |
chr11_-_96834771 | 3.46 |
ENSMUST00000107629.2
ENSMUST00000018803.12 |
Pnpo
|
pyridoxine 5'-phosphate oxidase |
chr16_+_43960183 | 3.46 |
ENSMUST00000159514.8
ENSMUST00000161326.8 ENSMUST00000063520.15 ENSMUST00000063542.8 |
Naa50
|
N(alpha)-acetyltransferase 50, NatE catalytic subunit |
chr12_+_17594795 | 3.46 |
ENSMUST00000171737.3
|
Odc1
|
ornithine decarboxylase, structural 1 |
chr18_+_21094477 | 3.45 |
ENSMUST00000234316.2
|
Rnf125
|
ring finger protein 125 |
chr4_-_131802561 | 3.44 |
ENSMUST00000105970.8
ENSMUST00000105975.8 |
Epb41
|
erythrocyte membrane protein band 4.1 |
chr11_+_114742331 | 3.43 |
ENSMUST00000177952.8
|
Gprc5c
|
G protein-coupled receptor, family C, group 5, member C |
chr19_-_41373526 | 3.43 |
ENSMUST00000059672.9
|
Pik3ap1
|
phosphoinositide-3-kinase adaptor protein 1 |
chrX_-_72965536 | 3.40 |
ENSMUST00000033763.15
|
Naa10
|
N(alpha)-acetyltransferase 10, NatA catalytic subunit |
chr6_-_83433357 | 3.40 |
ENSMUST00000186548.7
|
Tet3
|
tet methylcytosine dioxygenase 3 |
chr11_-_98980122 | 3.38 |
ENSMUST00000017751.3
|
Tns4
|
tensin 4 |
chr2_+_130116344 | 3.36 |
ENSMUST00000103198.11
|
Nop56
|
NOP56 ribonucleoprotein |
chr11_-_120715351 | 3.35 |
ENSMUST00000055655.9
|
Fasn
|
fatty acid synthase |
chr6_-_6217126 | 3.31 |
ENSMUST00000188414.4
|
Slc25a13
|
solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 13 |
chr11_+_100751272 | 3.31 |
ENSMUST00000107357.4
|
Stat5a
|
signal transducer and activator of transcription 5A |
chr6_+_17463925 | 3.30 |
ENSMUST00000115442.8
|
Met
|
met proto-oncogene |
chr10_+_77442026 | 3.30 |
ENSMUST00000129492.8
ENSMUST00000141228.9 |
Sumo3
|
small ubiquitin-like modifier 3 |
chr17_-_28705082 | 3.29 |
ENSMUST00000079413.11
|
Fkbp5
|
FK506 binding protein 5 |
chr17_-_33136021 | 3.28 |
ENSMUST00000054174.9
|
Cyp4f14
|
cytochrome P450, family 4, subfamily f, polypeptide 14 |
chr7_+_46495521 | 3.28 |
ENSMUST00000133062.2
|
Ldha
|
lactate dehydrogenase A |
chr8_+_41315479 | 3.27 |
ENSMUST00000141505.2
|
Slc7a2
|
solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 |
chr6_+_17463819 | 3.26 |
ENSMUST00000140070.8
|
Met
|
met proto-oncogene |
chr10_+_77442405 | 3.25 |
ENSMUST00000099538.6
|
Sumo3
|
small ubiquitin-like modifier 3 |
chr11_-_95966407 | 3.24 |
ENSMUST00000107686.8
ENSMUST00000107684.2 |
Atp5g1
|
ATP synthase, H+ transporting, mitochondrial F0 complex, subunit C1 (subunit 9) |
chr11_-_116089866 | 3.24 |
ENSMUST00000066587.12
|
Acox1
|
acyl-Coenzyme A oxidase 1, palmitoyl |
chr6_-_6217021 | 3.23 |
ENSMUST00000015256.15
|
Slc25a13
|
solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 13 |
chr17_-_28705055 | 3.22 |
ENSMUST00000233870.2
|
Fkbp5
|
FK506 binding protein 5 |
chr12_+_24701273 | 3.20 |
ENSMUST00000020982.7
|
Klf11
|
Kruppel-like factor 11 |
chr3_+_41519289 | 3.20 |
ENSMUST00000168086.7
|
Jade1
|
jade family PHD finger 1 |
chr8_+_105318067 | 3.20 |
ENSMUST00000059588.8
|
Pdp2
|
pyruvate dehyrogenase phosphatase catalytic subunit 2 |
chr17_-_56933872 | 3.19 |
ENSMUST00000047226.10
|
Lonp1
|
lon peptidase 1, mitochondrial |
chr11_+_96177449 | 3.19 |
ENSMUST00000049352.8
|
Hoxb7
|
homeobox B7 |
chr15_+_102829538 | 3.19 |
ENSMUST00000001700.7
|
Hoxc13
|
homeobox C13 |
chr4_+_24898074 | 3.19 |
ENSMUST00000029925.10
ENSMUST00000151249.2 |
Ndufaf4
|
NADH:ubiquinone oxidoreductase complex assembly factor 4 |
chr1_+_71596306 | 3.18 |
ENSMUST00000027384.6
|
Atic
|
5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase |
chr4_-_131802606 | 3.17 |
ENSMUST00000146021.8
|
Epb41
|
erythrocyte membrane protein band 4.1 |
chr10_-_4337435 | 3.16 |
ENSMUST00000100077.5
|
Zbtb2
|
zinc finger and BTB domain containing 2 |
chr14_+_21102642 | 3.16 |
ENSMUST00000045376.11
|
Adk
|
adenosine kinase |
chr14_+_21102662 | 3.15 |
ENSMUST00000223915.2
|
Adk
|
adenosine kinase |
chr7_-_127308059 | 3.15 |
ENSMUST00000061468.9
|
Bcl7c
|
B cell CLL/lymphoma 7C |
chr16_-_35311243 | 3.15 |
ENSMUST00000023550.9
|
Pdia5
|
protein disulfide isomerase associated 5 |
chr7_-_127307898 | 3.12 |
ENSMUST00000207019.2
|
Bcl7c
|
B cell CLL/lymphoma 7C |
chr4_+_152410291 | 3.12 |
ENSMUST00000103191.11
ENSMUST00000139685.8 ENSMUST00000188151.2 |
Rpl22
|
ribosomal protein L22 |
chr11_-_51647204 | 3.12 |
ENSMUST00000109092.8
ENSMUST00000064297.5 |
Sec24a
|
Sec24 related gene family, member A (S. cerevisiae) |
chr1_-_55127312 | 3.11 |
ENSMUST00000127861.8
ENSMUST00000144077.3 |
Hspd1
|
heat shock protein 1 (chaperonin) |
chr4_-_53159885 | 3.10 |
ENSMUST00000030010.4
|
Abca1
|
ATP-binding cassette, sub-family A (ABC1), member 1 |
chr17_+_71923210 | 3.07 |
ENSMUST00000047086.10
|
Wdr43
|
WD repeat domain 43 |
chr2_+_74593324 | 3.07 |
ENSMUST00000047793.6
|
Hoxd1
|
homeobox D1 |
chr17_+_45874800 | 3.07 |
ENSMUST00000224905.2
ENSMUST00000226086.2 ENSMUST00000041353.7 |
Slc35b2
|
solute carrier family 35, member B2 |
chr15_-_11399666 | 3.05 |
ENSMUST00000022849.7
|
Tars
|
threonyl-tRNA synthetase |
chr7_-_34354924 | 3.03 |
ENSMUST00000032709.3
|
Kctd15
|
potassium channel tetramerisation domain containing 15 |
chr7_-_25176959 | 3.02 |
ENSMUST00000098668.3
ENSMUST00000206687.2 ENSMUST00000206676.2 ENSMUST00000205308.2 ENSMUST00000098669.8 ENSMUST00000206171.2 ENSMUST00000098666.9 |
Ceacam1
|
carcinoembryonic antigen-related cell adhesion molecule 1 |
chr3_+_104545974 | 3.01 |
ENSMUST00000046212.2
|
Slc16a1
|
solute carrier family 16 (monocarboxylic acid transporters), member 1 |
chr15_+_81695615 | 3.01 |
ENSMUST00000023024.8
|
Tef
|
thyrotroph embryonic factor |
chr19_-_38113249 | 2.97 |
ENSMUST00000112335.4
|
Rbp4
|
retinol binding protein 4, plasma |
chr2_+_144112798 | 2.96 |
ENSMUST00000028910.9
ENSMUST00000110027.2 |
Mgme1
|
mitochondrial genome maintenance exonuclease 1 |
chr16_-_4376471 | 2.95 |
ENSMUST00000230875.2
|
Tfap4
|
transcription factor AP4 |
chr4_-_41741278 | 2.95 |
ENSMUST00000059354.15
ENSMUST00000071561.7 |
Sigmar1
|
sigma non-opioid intracellular receptor 1 |
chr3_-_107993906 | 2.94 |
ENSMUST00000102638.8
ENSMUST00000102637.8 |
Ampd2
|
adenosine monophosphate deaminase 2 |
chr5_+_3391477 | 2.92 |
ENSMUST00000199156.2
|
Cdk6
|
cyclin-dependent kinase 6 |
chr9_+_108216233 | 2.91 |
ENSMUST00000082429.8
|
Gpx1
|
glutathione peroxidase 1 |
chrX_+_138464065 | 2.90 |
ENSMUST00000113027.8
|
Rnf128
|
ring finger protein 128 |
chr12_-_77008799 | 2.88 |
ENSMUST00000218640.2
|
Max
|
Max protein |
chr16_+_23044763 | 2.88 |
ENSMUST00000178797.8
|
St6gal1
|
beta galactoside alpha 2,6 sialyltransferase 1 |
chr6_-_47790272 | 2.88 |
ENSMUST00000077290.9
|
Pdia4
|
protein disulfide isomerase associated 4 |
chr10_+_125802084 | 2.88 |
ENSMUST00000074807.8
|
Lrig3
|
leucine-rich repeats and immunoglobulin-like domains 3 |
chr2_+_144112542 | 2.88 |
ENSMUST00000110028.8
|
Mgme1
|
mitochondrial genome maintenance exonuclease 1 |
chr12_+_8821404 | 2.86 |
ENSMUST00000171158.8
|
Sdc1
|
syndecan 1 |
chr10_-_127724557 | 2.86 |
ENSMUST00000047199.5
|
Rdh7
|
retinol dehydrogenase 7 |
chr4_+_20008357 | 2.85 |
ENSMUST00000117632.8
ENSMUST00000098244.2 |
Ttpa
|
tocopherol (alpha) transfer protein |
chr12_+_8821317 | 2.83 |
ENSMUST00000020911.14
|
Sdc1
|
syndecan 1 |
chr11_-_69812053 | 2.81 |
ENSMUST00000108613.10
ENSMUST00000043419.10 ENSMUST00000070996.11 |
Eif5a
|
eukaryotic translation initiation factor 5A |
chr3_+_106389732 | 2.79 |
ENSMUST00000029508.11
|
Dennd2d
|
DENN/MADD domain containing 2D |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.9 | 11.6 | GO:0033128 | positive regulation of reciprocal meiotic recombination(GO:0010845) negative regulation of histone phosphorylation(GO:0033128) |
3.8 | 26.4 | GO:0010288 | response to lead ion(GO:0010288) |
3.7 | 11.2 | GO:0003167 | atrioventricular bundle cell differentiation(GO:0003167) |
3.6 | 10.9 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
3.4 | 10.1 | GO:0034226 | nitric oxide production involved in inflammatory response(GO:0002537) lysine import(GO:0034226) L-lysine import(GO:0061461) L-ornithine transmembrane transport(GO:1903352) L-arginine transmembrane transport(GO:1903400) L-lysine transmembrane transport(GO:1903401) L-lysine import into cell(GO:1903410) arginine transmembrane transport(GO:1903826) |
3.3 | 13.0 | GO:0010269 | response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) response to selenium ion(GO:0010269) |
3.1 | 15.4 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
2.6 | 7.8 | GO:0019264 | glycine biosynthetic process from serine(GO:0019264) |
2.4 | 7.2 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
2.2 | 11.0 | GO:1902724 | positive regulation of skeletal muscle satellite cell proliferation(GO:1902724) positive regulation of growth factor dependent skeletal muscle satellite cell proliferation(GO:1902728) |
2.2 | 8.7 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
2.1 | 6.3 | GO:0006169 | adenosine salvage(GO:0006169) dATP biosynthetic process(GO:0006175) |
2.0 | 8.1 | GO:0034285 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
1.9 | 5.8 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
1.9 | 11.6 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
1.9 | 5.7 | GO:0048627 | myoblast development(GO:0048627) |
1.7 | 13.9 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
1.6 | 4.8 | GO:0002014 | vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure(GO:0002014) |
1.6 | 9.4 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
1.5 | 6.0 | GO:0010046 | response to mycotoxin(GO:0010046) |
1.4 | 5.8 | GO:0060265 | positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
1.4 | 4.3 | GO:0046168 | glycerol-3-phosphate catabolic process(GO:0046168) |
1.4 | 11.4 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
1.4 | 4.3 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
1.4 | 4.3 | GO:0046901 | tetrahydrofolylpolyglutamate biosynthetic process(GO:0046901) |
1.4 | 6.9 | GO:0044268 | multicellular organismal protein metabolic process(GO:0044268) |
1.4 | 4.1 | GO:0006059 | hexitol metabolic process(GO:0006059) |
1.4 | 4.1 | GO:0002414 | immune response in mucosal-associated lymphoid tissue(GO:0002386) immunoglobulin transcytosis in epithelial cells(GO:0002414) |
1.3 | 4.0 | GO:0032877 | positive regulation of DNA endoreduplication(GO:0032877) |
1.3 | 6.5 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
1.3 | 3.9 | GO:0002352 | B cell negative selection(GO:0002352) release of matrix enzymes from mitochondria(GO:0032976) B cell receptor apoptotic signaling pathway(GO:1990117) |
1.3 | 3.9 | GO:0014908 | myotube differentiation involved in skeletal muscle regeneration(GO:0014908) |
1.2 | 3.6 | GO:0043323 | positive regulation of natural killer cell degranulation(GO:0043323) |
1.2 | 4.8 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
1.2 | 4.8 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
1.2 | 3.5 | GO:0042822 | pyridoxal phosphate metabolic process(GO:0042822) |
1.1 | 4.6 | GO:1903760 | regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903760) |
1.1 | 1.1 | GO:1900369 | negative regulation of RNA interference(GO:1900369) |
1.1 | 4.5 | GO:0072717 | cellular response to actinomycin D(GO:0072717) |
1.1 | 3.4 | GO:0033306 | phytol metabolic process(GO:0033306) fatty alcohol metabolic process(GO:1903173) |
1.1 | 5.4 | GO:0019072 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
1.1 | 4.3 | GO:1904008 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) response to monosodium glutamate(GO:1904008) cellular response to monosodium glutamate(GO:1904009) |
1.0 | 5.1 | GO:1902167 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902167) |
1.0 | 9.2 | GO:0000050 | urea cycle(GO:0000050) |
1.0 | 4.1 | GO:0009257 | histidine biosynthetic process(GO:0000105) 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
1.0 | 3.0 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
1.0 | 5.0 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
1.0 | 2.9 | GO:0036275 | response to 5-fluorouracil(GO:0036275) |
1.0 | 11.6 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
1.0 | 2.9 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.9 | 12.1 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.9 | 5.5 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.9 | 3.6 | GO:0035973 | aggrephagy(GO:0035973) protein lipidation involved in autophagosome assembly(GO:0061739) |
0.9 | 3.6 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.9 | 6.2 | GO:0015862 | uridine transport(GO:0015862) |
0.9 | 2.7 | GO:0042694 | muscle cell fate specification(GO:0042694) |
0.9 | 0.9 | GO:0046051 | UTP metabolic process(GO:0046051) |
0.9 | 7.1 | GO:0019660 | glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.9 | 3.5 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.9 | 2.7 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
0.9 | 2.6 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
0.9 | 11.4 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.9 | 9.5 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.8 | 1.7 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.8 | 2.5 | GO:0002270 | plasmacytoid dendritic cell activation(GO:0002270) |
0.8 | 2.5 | GO:0006740 | NADPH regeneration(GO:0006740) |
0.8 | 5.9 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.8 | 3.3 | GO:0060376 | positive regulation of mast cell differentiation(GO:0060376) |
0.8 | 2.5 | GO:1904933 | regulation of cell proliferation in midbrain(GO:1904933) |
0.8 | 4.1 | GO:0009446 | putrescine biosynthetic process(GO:0009446) putrescine biosynthetic process from ornithine(GO:0033387) |
0.8 | 2.4 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
0.8 | 4.0 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.8 | 2.4 | GO:0034963 | box C/D snoRNA 3'-end processing(GO:0000494) box C/D snoRNA metabolic process(GO:0033967) box C/D snoRNA processing(GO:0034963) histone glutamine methylation(GO:1990258) |
0.8 | 5.4 | GO:0015886 | heme transport(GO:0015886) |
0.8 | 2.3 | GO:1903632 | positive regulation of aminoacyl-tRNA ligase activity(GO:1903632) |
0.8 | 5.4 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.8 | 2.3 | GO:0034201 | response to oleic acid(GO:0034201) |
0.8 | 3.0 | GO:0002856 | negative regulation of natural killer cell mediated immune response to tumor cell(GO:0002856) negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002859) positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
0.7 | 3.7 | GO:0045917 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.7 | 3.0 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.7 | 2.9 | GO:0019343 | cysteine biosynthetic process via cystathionine(GO:0019343) |
0.7 | 3.6 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
0.7 | 5.0 | GO:0002003 | angiotensin maturation(GO:0002003) |
0.7 | 5.7 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.7 | 2.8 | GO:0060849 | regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
0.7 | 3.4 | GO:0044727 | DNA demethylation of male pronucleus(GO:0044727) |
0.7 | 2.7 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.7 | 0.7 | GO:0035802 | adrenal cortex development(GO:0035801) adrenal cortex formation(GO:0035802) |
0.7 | 5.9 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.6 | 7.7 | GO:2000232 | regulation of rRNA processing(GO:2000232) |
0.6 | 1.9 | GO:0071579 | regulation of zinc ion transport(GO:0071579) |
0.6 | 4.4 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.6 | 1.3 | GO:0002188 | translation reinitiation(GO:0002188) |
0.6 | 1.9 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.6 | 1.9 | GO:0036363 | transforming growth factor beta activation(GO:0036363) |
0.6 | 3.1 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
0.6 | 2.5 | GO:0019064 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.6 | 1.2 | GO:1904867 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) |
0.6 | 1.8 | GO:0040031 | snRNA modification(GO:0040031) |
0.6 | 6.0 | GO:1903797 | positive regulation of inorganic anion transmembrane transport(GO:1903797) |
0.6 | 2.4 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.6 | 3.5 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
0.6 | 1.8 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.6 | 2.9 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.6 | 4.1 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.6 | 0.6 | GO:0060702 | negative regulation of ribonuclease activity(GO:0060701) negative regulation of endoribonuclease activity(GO:0060702) |
0.6 | 2.9 | GO:1990743 | protein sialylation(GO:1990743) |
0.6 | 5.2 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.6 | 3.4 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.6 | 1.7 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.6 | 5.1 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.6 | 1.1 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.6 | 3.3 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
0.6 | 2.2 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.6 | 1.7 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.5 | 1.1 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.5 | 2.2 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.5 | 0.5 | GO:0002085 | inhibition of neuroepithelial cell differentiation(GO:0002085) |
0.5 | 2.1 | GO:0016999 | antibiotic metabolic process(GO:0016999) |
0.5 | 11.7 | GO:1904816 | positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
0.5 | 1.1 | GO:0014858 | positive regulation of skeletal muscle cell proliferation(GO:0014858) |
0.5 | 4.2 | GO:0046504 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.5 | 6.2 | GO:0006477 | protein sulfation(GO:0006477) |
0.5 | 5.2 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.5 | 1.6 | GO:0006583 | melanin biosynthetic process from tyrosine(GO:0006583) |
0.5 | 28.6 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.5 | 2.0 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
0.5 | 1.5 | GO:0006713 | glucocorticoid catabolic process(GO:0006713) |
0.5 | 3.6 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
0.5 | 1.5 | GO:0045660 | positive regulation of neutrophil differentiation(GO:0045660) |
0.5 | 1.5 | GO:0003430 | growth plate cartilage chondrocyte growth(GO:0003430) |
0.5 | 1.5 | GO:1903976 | negative regulation of glial cell migration(GO:1903976) |
0.5 | 2.0 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.5 | 2.0 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.5 | 2.5 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.5 | 1.5 | GO:0010816 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
0.5 | 1.9 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.5 | 1.9 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
0.5 | 3.8 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.5 | 2.9 | GO:0032763 | regulation of mast cell cytokine production(GO:0032763) |
0.5 | 0.9 | GO:0060066 | oviduct development(GO:0060066) |
0.5 | 1.4 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
0.5 | 2.3 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.5 | 3.7 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.5 | 3.6 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.4 | 3.1 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.4 | 7.0 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.4 | 1.3 | GO:0051695 | actin filament uncapping(GO:0051695) phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
0.4 | 4.3 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.4 | 1.3 | GO:0042262 | DNA protection(GO:0042262) |
0.4 | 1.7 | GO:1904457 | positive regulation of neuronal action potential(GO:1904457) |
0.4 | 0.4 | GO:0002501 | MHC protein complex assembly(GO:0002396) peptide antigen assembly with MHC protein complex(GO:0002501) |
0.4 | 2.1 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.4 | 1.2 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
0.4 | 1.2 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.4 | 1.6 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
0.4 | 3.7 | GO:0044351 | macropinocytosis(GO:0044351) |
0.4 | 0.8 | GO:0000066 | mitochondrial ornithine transport(GO:0000066) |
0.4 | 4.8 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
0.4 | 4.0 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.4 | 1.6 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.4 | 10.2 | GO:0051639 | actin filament network formation(GO:0051639) |
0.4 | 1.2 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.4 | 1.2 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.4 | 1.2 | GO:1901053 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
0.4 | 5.9 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.4 | 1.6 | GO:0010286 | heat acclimation(GO:0010286) |
0.4 | 1.9 | GO:1901355 | response to rapamycin(GO:1901355) |
0.4 | 2.3 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.4 | 2.3 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
0.4 | 2.6 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.4 | 7.8 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.4 | 4.1 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.4 | 1.8 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
0.4 | 2.6 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.4 | 5.5 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.4 | 3.3 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.4 | 10.8 | GO:0061318 | renal filtration cell differentiation(GO:0061318) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.4 | 1.4 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) leading strand elongation(GO:0006272) |
0.4 | 7.2 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.4 | 4.3 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.4 | 2.8 | GO:0071569 | protein ufmylation(GO:0071569) |
0.3 | 4.2 | GO:2000484 | positive regulation of interleukin-8 secretion(GO:2000484) |
0.3 | 0.7 | GO:0007494 | midgut development(GO:0007494) |
0.3 | 1.4 | GO:1990091 | positive regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014718) sodium-dependent self proteolysis(GO:1990091) |
0.3 | 1.4 | GO:0050812 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.3 | 9.3 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.3 | 2.1 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.3 | 2.0 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
0.3 | 2.4 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.3 | 3.7 | GO:1901249 | regulation of lung goblet cell differentiation(GO:1901249) negative regulation of lung goblet cell differentiation(GO:1901250) |
0.3 | 0.3 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.3 | 1.7 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.3 | 6.0 | GO:1904776 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.3 | 6.2 | GO:0032933 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.3 | 5.2 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.3 | 1.0 | GO:0036446 | myofibroblast differentiation(GO:0036446) regulation of myofibroblast differentiation(GO:1904760) negative regulation of myofibroblast differentiation(GO:1904761) |
0.3 | 5.5 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.3 | 4.2 | GO:0043247 | telomere maintenance in response to DNA damage(GO:0043247) |
0.3 | 3.9 | GO:0035878 | nail development(GO:0035878) |
0.3 | 1.6 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.3 | 1.0 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.3 | 0.6 | GO:0061623 | glycolytic process from galactose(GO:0061623) |
0.3 | 0.9 | GO:0010767 | regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage(GO:0010767) |
0.3 | 5.0 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.3 | 3.4 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.3 | 0.9 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.3 | 9.1 | GO:0000154 | rRNA modification(GO:0000154) |
0.3 | 0.9 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.3 | 0.9 | GO:0009107 | lipoate biosynthetic process(GO:0009107) |
0.3 | 1.2 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.3 | 0.9 | GO:0060574 | intestinal epithelial cell maturation(GO:0060574) |
0.3 | 2.1 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.3 | 3.5 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.3 | 5.6 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.3 | 1.8 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
0.3 | 0.3 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.3 | 0.9 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
0.3 | 1.5 | GO:0010157 | response to chlorate(GO:0010157) |
0.3 | 5.4 | GO:1990403 | embryonic brain development(GO:1990403) |
0.3 | 1.1 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.3 | 12.2 | GO:0051351 | positive regulation of ligase activity(GO:0051351) |
0.3 | 0.9 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.3 | 4.5 | GO:0006085 | acetyl-CoA biosynthetic process(GO:0006085) |
0.3 | 2.2 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.3 | 0.8 | GO:0018160 | peptidyl-pyrromethane cofactor linkage(GO:0018160) |
0.3 | 0.8 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.3 | 0.6 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.3 | 1.4 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.3 | 1.4 | GO:0045343 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
0.3 | 6.2 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.3 | 1.9 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.3 | 3.5 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.3 | 5.4 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.3 | 2.4 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
0.3 | 1.6 | GO:0043366 | beta selection(GO:0043366) |
0.3 | 1.1 | GO:0030450 | regulation of complement activation, classical pathway(GO:0030450) |
0.3 | 1.3 | GO:1904253 | positive regulation of bile acid biosynthetic process(GO:0070859) positive regulation of bile acid metabolic process(GO:1904253) |
0.3 | 4.4 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.3 | 1.6 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.3 | 2.8 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.3 | 3.3 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.3 | 1.8 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
0.3 | 1.3 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.3 | 5.0 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.3 | 1.0 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
0.3 | 3.0 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.3 | 3.3 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.2 | 2.7 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.2 | 3.5 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.2 | 1.5 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.2 | 2.2 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.2 | 1.7 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.2 | 1.9 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.2 | 1.2 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.2 | 3.1 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.2 | 0.2 | GO:0051977 | lysophospholipid transport(GO:0051977) lipid transport across blood brain barrier(GO:1990379) |
0.2 | 5.0 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.2 | 0.5 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.2 | 0.7 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.2 | 1.2 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.2 | 8.6 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.2 | 4.2 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.2 | 1.2 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.2 | 1.6 | GO:0015871 | choline transport(GO:0015871) |
0.2 | 3.2 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.2 | 0.5 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.2 | 1.6 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.2 | 2.2 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.2 | 1.3 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.2 | 6.6 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.2 | 0.4 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
0.2 | 0.7 | GO:0046038 | GMP catabolic process(GO:0046038) |
0.2 | 0.7 | GO:0000349 | generation of catalytic spliceosome for first transesterification step(GO:0000349) |
0.2 | 0.6 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.2 | 1.5 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.2 | 14.2 | GO:0015807 | L-amino acid transport(GO:0015807) |
0.2 | 0.2 | GO:0048254 | snoRNA localization(GO:0048254) |
0.2 | 1.3 | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
0.2 | 0.6 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
0.2 | 1.3 | GO:0032226 | positive regulation of synaptic transmission, dopaminergic(GO:0032226) |
0.2 | 0.6 | GO:0000430 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) positive regulation of transcription by glucose(GO:0046016) |
0.2 | 1.2 | GO:0071699 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.2 | 1.5 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.2 | 1.6 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) abortive mitotic cell cycle(GO:0033277) |
0.2 | 1.2 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
0.2 | 0.4 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.2 | 0.6 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
0.2 | 0.8 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.2 | 3.2 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.2 | 1.2 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.2 | 0.8 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.2 | 0.4 | GO:0034970 | histone H3-R2 methylation(GO:0034970) |
0.2 | 1.6 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.2 | 1.8 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.2 | 1.4 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.2 | 1.0 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.2 | 0.4 | GO:0035470 | positive regulation of vascular wound healing(GO:0035470) |
0.2 | 1.0 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.2 | 1.9 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.2 | 0.9 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.2 | 0.6 | GO:2000819 | regulation of nucleotide-excision repair(GO:2000819) |
0.2 | 0.7 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.2 | 2.2 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.2 | 1.1 | GO:0006983 | ER overload response(GO:0006983) |
0.2 | 0.9 | GO:0018101 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.2 | 3.4 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.2 | 0.9 | GO:0006544 | glycine metabolic process(GO:0006544) |
0.2 | 0.9 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.2 | 1.9 | GO:0001842 | neural fold formation(GO:0001842) |
0.2 | 0.7 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) positive regulation of progesterone secretion(GO:2000872) |
0.2 | 4.7 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.2 | 0.9 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.2 | 8.6 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.2 | 4.3 | GO:0006907 | pinocytosis(GO:0006907) |
0.2 | 3.6 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
0.2 | 1.9 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.2 | 2.4 | GO:1902176 | negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902176) |
0.2 | 3.6 | GO:0060065 | uterus development(GO:0060065) |
0.2 | 1.3 | GO:1902961 | positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) positive regulation of aspartic-type peptidase activity(GO:1905247) |
0.2 | 1.3 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.2 | 1.0 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.2 | 2.7 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.2 | 4.0 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.2 | 1.5 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.2 | 0.2 | GO:0046549 | retinal cone cell development(GO:0046549) |
0.2 | 0.5 | GO:0032847 | regulation of cellular pH reduction(GO:0032847) positive regulation of cellular pH reduction(GO:0032849) |
0.2 | 3.2 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.2 | 5.0 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.2 | 0.3 | GO:0003264 | cardioblast proliferation(GO:0003263) regulation of cardioblast proliferation(GO:0003264) |
0.2 | 0.9 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.2 | 2.8 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.2 | 2.8 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.2 | 0.8 | GO:0043056 | forward locomotion(GO:0043056) |
0.2 | 4.8 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.2 | 1.2 | GO:1990144 | intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
0.2 | 0.5 | GO:0034287 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.2 | 0.6 | GO:2000795 | lung ciliated cell differentiation(GO:0061141) negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
0.2 | 0.6 | GO:0070625 | zymogen granule exocytosis(GO:0070625) |
0.2 | 6.6 | GO:0006414 | translational elongation(GO:0006414) |
0.1 | 0.6 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 2.8 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.1 | 0.7 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
0.1 | 0.6 | GO:0010872 | regulation of cholesterol esterification(GO:0010872) |
0.1 | 5.3 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.1 | 0.7 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.1 | 0.6 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.1 | 1.6 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.1 | 0.3 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.1 | 2.8 | GO:0001502 | cartilage condensation(GO:0001502) |
0.1 | 6.2 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.1 | 0.7 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.1 | 0.8 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.1 | 3.2 | GO:0014823 | response to activity(GO:0014823) |
0.1 | 2.8 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.1 | 0.7 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
0.1 | 4.0 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.1 | 4.0 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
0.1 | 1.0 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.1 | 0.5 | GO:0009816 | defense response, incompatible interaction(GO:0009814) defense response to bacterium, incompatible interaction(GO:0009816) regulation of defense response to bacterium, incompatible interaction(GO:1902477) |
0.1 | 1.2 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 0.4 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
0.1 | 3.7 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.1 | 0.4 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.1 | 2.8 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.1 | 1.1 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.1 | 0.9 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.1 | 0.7 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.1 | 1.0 | GO:0015791 | polyol transport(GO:0015791) |
0.1 | 0.4 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) mitochondrial tRNA 3'-end processing(GO:1990180) |
0.1 | 1.0 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.1 | 1.4 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.1 | 1.4 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.1 | 1.3 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.1 | 0.4 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.1 | 0.3 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
0.1 | 1.9 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.1 | 2.4 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.1 | 0.8 | GO:0070459 | prolactin secretion(GO:0070459) |
0.1 | 1.1 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.1 | 0.7 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.1 | 1.5 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.1 | 0.4 | GO:2001166 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
0.1 | 3.6 | GO:0055090 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.1 | 2.2 | GO:0030220 | platelet formation(GO:0030220) |
0.1 | 1.0 | GO:0007000 | nucleolus organization(GO:0007000) |
0.1 | 1.2 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.1 | 0.5 | GO:0043418 | homocysteine catabolic process(GO:0043418) |
0.1 | 4.0 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.1 | 3.8 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.1 | 1.7 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 2.7 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.1 | 0.9 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.1 | 0.5 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.1 | 0.6 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.1 | 2.8 | GO:0045780 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
0.1 | 0.7 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
0.1 | 0.7 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
0.1 | 0.2 | GO:0051794 | regulation of catagen(GO:0051794) |
0.1 | 1.4 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.1 | 0.3 | GO:0035822 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
0.1 | 2.7 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.5 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.1 | 0.8 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
0.1 | 0.3 | GO:0072347 | response to anesthetic(GO:0072347) |
0.1 | 0.6 | GO:0014029 | neural crest formation(GO:0014029) |
0.1 | 0.5 | GO:0098734 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.1 | 1.3 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 0.5 | GO:1902949 | positive regulation of tau-protein kinase activity(GO:1902949) |
0.1 | 0.3 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.1 | 0.4 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.1 | 2.6 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.1 | 0.9 | GO:0045072 | regulation of interferon-gamma biosynthetic process(GO:0045072) positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.1 | 1.1 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.1 | 1.4 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.1 | 0.3 | GO:1903438 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
0.1 | 0.4 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.1 | 0.1 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.1 | 0.8 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.1 | 1.3 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.1 | 2.1 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.1 | 0.2 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.1 | 4.6 | GO:0035019 | somatic stem cell population maintenance(GO:0035019) |
0.1 | 1.0 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.1 | 1.3 | GO:0097435 | fibril organization(GO:0097435) |
0.1 | 3.2 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.1 | 0.5 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.1 | 0.8 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.1 | 2.3 | GO:0055069 | zinc ion homeostasis(GO:0055069) |
0.1 | 1.8 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
0.1 | 0.1 | GO:0000912 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
0.1 | 3.4 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.1 | 0.6 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.1 | 0.4 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.1 | 1.9 | GO:0099514 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.1 | 3.6 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.1 | 2.7 | GO:0045604 | regulation of epidermal cell differentiation(GO:0045604) |
0.1 | 0.6 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.1 | 0.9 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.1 | 0.6 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.1 | 0.2 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.1 | 0.7 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.1 | 1.8 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.1 | 0.2 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.1 | 0.2 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
0.1 | 1.6 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.1 | 0.5 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.1 | 0.5 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.1 | 0.4 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.1 | 0.6 | GO:1905214 | regulation of mRNA binding(GO:1902415) positive regulation of mRNA binding(GO:1902416) regulation of RNA binding(GO:1905214) positive regulation of RNA binding(GO:1905216) |
0.1 | 0.3 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.1 | 0.8 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.1 | 0.8 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.1 | 0.3 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.1 | 0.5 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.1 | 1.1 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.1 | 0.4 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.1 | 0.5 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.1 | 1.0 | GO:0034312 | diol biosynthetic process(GO:0034312) |
0.1 | 0.2 | GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
0.1 | 2.0 | GO:0030488 | tRNA methylation(GO:0030488) |
0.1 | 0.6 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.1 | 0.6 | GO:0009644 | response to high light intensity(GO:0009644) |
0.1 | 3.2 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.1 | 0.3 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.1 | 0.3 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.1 | 0.8 | GO:0021554 | optic nerve development(GO:0021554) |
0.1 | 0.2 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.1 | 0.1 | GO:0071431 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
0.1 | 6.0 | GO:0048704 | embryonic skeletal system morphogenesis(GO:0048704) |
0.1 | 0.7 | GO:0008228 | opsonization(GO:0008228) |
0.1 | 0.2 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.1 | 0.9 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.1 | 1.0 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.1 | 0.6 | GO:0046321 | positive regulation of fatty acid oxidation(GO:0046321) |
0.1 | 0.3 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
0.1 | 0.5 | GO:0040038 | polar body extrusion after meiotic divisions(GO:0040038) spindle assembly involved in meiosis(GO:0090306) |
0.1 | 0.7 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) |
0.1 | 3.8 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.1 | 1.8 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.1 | 0.5 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.1 | 0.1 | GO:0000448 | cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000448) |
0.1 | 0.4 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.1 | 1.0 | GO:0071450 | removal of superoxide radicals(GO:0019430) cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) |
0.1 | 0.2 | GO:0046351 | disaccharide biosynthetic process(GO:0046351) |
0.1 | 0.7 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.1 | 0.9 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 1.8 | GO:0030901 | midbrain development(GO:0030901) |
0.1 | 1.5 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.1 | 0.8 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.1 | 0.5 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.1 | 0.7 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.1 | 0.7 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.1 | 0.5 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.1 | 0.7 | GO:0010586 | miRNA metabolic process(GO:0010586) |
0.1 | 0.6 | GO:0045176 | apical protein localization(GO:0045176) |
0.1 | 2.7 | GO:0007520 | myoblast fusion(GO:0007520) |
0.1 | 0.4 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.1 | 1.4 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 0.1 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.1 | 0.3 | GO:1903422 | negative regulation of synaptic vesicle recycling(GO:1903422) |
0.1 | 1.4 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.1 | 0.3 | GO:0002063 | chondrocyte development(GO:0002063) |
0.1 | 1.2 | GO:0010259 | multicellular organism aging(GO:0010259) |
0.1 | 0.3 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.1 | 0.9 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 8.5 | GO:0007601 | visual perception(GO:0007601) |
0.1 | 1.2 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) |
0.1 | 1.2 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.0 | 0.8 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.0 | 0.3 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.0 | 0.4 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.0 | 0.8 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.0 | 0.5 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.0 | 0.4 | GO:0051450 | myoblast proliferation(GO:0051450) |
0.0 | 0.6 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.0 | 0.1 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.0 | 0.2 | GO:0090343 | positive regulation of cell aging(GO:0090343) |
0.0 | 1.3 | GO:0009880 | embryonic pattern specification(GO:0009880) |
0.0 | 0.2 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.0 | 2.2 | GO:0009250 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.0 | 0.8 | GO:0006400 | tRNA modification(GO:0006400) |
0.0 | 0.8 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.0 | 0.2 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.0 | 1.0 | GO:0001709 | cell fate determination(GO:0001709) |
0.0 | 1.1 | GO:0006582 | melanin metabolic process(GO:0006582) melanin biosynthetic process(GO:0042438) |
0.0 | 0.3 | GO:0032310 | prostaglandin secretion(GO:0032310) |
0.0 | 0.2 | GO:0015904 | tetracycline transport(GO:0015904) |
0.0 | 1.2 | GO:0031640 | killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
0.0 | 0.7 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.0 | 0.9 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.0 | 0.5 | GO:0006968 | cellular defense response(GO:0006968) |
0.0 | 0.4 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.0 | 1.1 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.0 | 0.3 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.0 | 0.7 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 1.9 | GO:0050850 | positive regulation of calcium-mediated signaling(GO:0050850) |
0.0 | 0.9 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.0 | 0.1 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
0.0 | 0.5 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.0 | 0.6 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.0 | 0.4 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.0 | 0.5 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.0 | 0.2 | GO:0015669 | gas transport(GO:0015669) |
0.0 | 1.1 | GO:0031648 | protein destabilization(GO:0031648) |
0.0 | 4.8 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.0 | 0.5 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.0 | 0.2 | GO:0044783 | G1 DNA damage checkpoint(GO:0044783) |
0.0 | 0.3 | GO:1900194 | negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
0.0 | 0.5 | GO:0006825 | copper ion transport(GO:0006825) |
0.0 | 0.3 | GO:1904030 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.0 | 1.3 | GO:0051897 | positive regulation of protein kinase B signaling(GO:0051897) |
0.0 | 0.2 | GO:0071549 | response to dexamethasone(GO:0071548) cellular response to dexamethasone stimulus(GO:0071549) |
0.0 | 0.3 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.0 | 0.1 | GO:0046049 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.0 | 1.1 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.0 | 0.2 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.0 | 0.1 | GO:0032070 | regulation of deoxyribonuclease activity(GO:0032070) |
0.0 | 0.3 | GO:2000772 | regulation of cellular senescence(GO:2000772) |
0.0 | 0.4 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.0 | 0.6 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.0 | 0.2 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.0 | 0.1 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.0 | 1.1 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.0 | 1.0 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
0.0 | 5.0 | GO:0006486 | protein glycosylation(GO:0006486) macromolecule glycosylation(GO:0043413) |
0.0 | 0.1 | GO:0023019 | signal transduction involved in regulation of gene expression(GO:0023019) |
0.0 | 1.8 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.0 | 0.2 | GO:0021877 | forebrain neuron fate commitment(GO:0021877) |
0.0 | 1.0 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.0 | 3.3 | GO:0007219 | Notch signaling pathway(GO:0007219) |
0.0 | 0.5 | GO:0043276 | anoikis(GO:0043276) |
0.0 | 0.1 | GO:0018201 | peptidyl-glycine modification(GO:0018201) |
0.0 | 0.4 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.0 | 0.1 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.0 | 0.3 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.0 | 0.2 | GO:0055012 | ventricular cardiac muscle cell differentiation(GO:0055012) |
0.0 | 0.3 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.6 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.0 | 0.4 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.0 | 1.3 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.0 | 0.2 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.0 | 0.3 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.0 | 0.3 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.0 | 0.2 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.0 | 0.6 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.0 | 0.1 | GO:0032241 | positive regulation of nucleobase-containing compound transport(GO:0032241) |
0.0 | 0.1 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.0 | 0.1 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.0 | 1.1 | GO:0046324 | regulation of glucose import(GO:0046324) |
0.0 | 0.5 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.0 | 0.4 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.2 | GO:0030242 | pexophagy(GO:0030242) |
0.0 | 0.7 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.0 | 0.2 | GO:1900078 | positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.0 | 0.7 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.0 | 0.2 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.0 | 0.2 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.0 | 0.1 | GO:0046479 | glycolipid catabolic process(GO:0019377) glycosphingolipid catabolic process(GO:0046479) |
0.0 | 0.9 | GO:0010906 | regulation of glucose metabolic process(GO:0010906) |
0.0 | 0.1 | GO:0044108 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) cellular alcohol metabolic process(GO:0044107) cellular alcohol biosynthetic process(GO:0044108) |
0.0 | 0.3 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.0 | 0.2 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.0 | 1.1 | GO:0017015 | regulation of transforming growth factor beta receptor signaling pathway(GO:0017015) regulation of cellular response to transforming growth factor beta stimulus(GO:1903844) |
0.0 | 0.4 | GO:0035196 | production of miRNAs involved in gene silencing by miRNA(GO:0035196) |
0.0 | 0.1 | GO:0019471 | 4-hydroxyproline metabolic process(GO:0019471) |
0.0 | 0.1 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.0 | 0.1 | GO:0044818 | mitotic G2/M transition checkpoint(GO:0044818) |
0.0 | 0.0 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
0.0 | 0.2 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
0.0 | 0.2 | GO:0021513 | spinal cord dorsal/ventral patterning(GO:0021513) |
0.0 | 0.6 | GO:0032526 | response to retinoic acid(GO:0032526) |
0.0 | 0.3 | GO:0055006 | cardiac cell development(GO:0055006) |
0.0 | 0.3 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.0 | 1.5 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.3 | 26.4 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
3.1 | 9.2 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
1.6 | 13.1 | GO:0097413 | Lewy body(GO:0097413) |
1.5 | 11.9 | GO:0033503 | HULC complex(GO:0033503) |
1.3 | 12.0 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
1.3 | 3.9 | GO:0097144 | BAX complex(GO:0097144) |
1.3 | 15.5 | GO:0031415 | NatA complex(GO:0031415) |
1.2 | 3.6 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
1.2 | 3.6 | GO:0061474 | phagolysosome membrane(GO:0061474) |
1.2 | 9.3 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
1.1 | 1.1 | GO:0005757 | mitochondrial permeability transition pore complex(GO:0005757) |
1.1 | 4.4 | GO:0097447 | dendritic tree(GO:0097447) |
1.1 | 7.4 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
1.0 | 11.0 | GO:0042587 | glycogen granule(GO:0042587) |
1.0 | 2.9 | GO:0097132 | cyclin D2-CDK6 complex(GO:0097132) |
0.9 | 2.8 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.9 | 5.3 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.9 | 5.2 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.9 | 4.3 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.9 | 4.3 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.8 | 3.2 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
0.8 | 10.0 | GO:0005642 | annulate lamellae(GO:0005642) |
0.6 | 3.7 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.6 | 8.0 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.6 | 4.3 | GO:0005638 | lamin filament(GO:0005638) |
0.6 | 4.6 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.6 | 5.7 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.6 | 1.7 | GO:0090537 | CERF complex(GO:0090537) |
0.6 | 1.7 | GO:1990590 | ATF1-ATF4 transcription factor complex(GO:1990590) |
0.5 | 3.2 | GO:0097452 | GAIT complex(GO:0097452) |
0.5 | 4.3 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.5 | 7.7 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.5 | 8.7 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.5 | 1.4 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.4 | 1.3 | GO:0042721 | mitochondrial inner membrane protein insertion complex(GO:0042721) |
0.4 | 1.3 | GO:0043614 | multi-eIF complex(GO:0043614) |
0.4 | 2.0 | GO:0017177 | glucosidase II complex(GO:0017177) |
0.4 | 2.0 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.4 | 4.7 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.4 | 1.2 | GO:0032156 | septin cytoskeleton(GO:0032156) |
0.4 | 1.5 | GO:0031680 | G-protein beta/gamma-subunit complex(GO:0031680) |
0.4 | 3.6 | GO:0070552 | BRISC complex(GO:0070552) |
0.4 | 5.0 | GO:0031983 | vesicle lumen(GO:0031983) |
0.4 | 6.4 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.4 | 2.5 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.4 | 1.4 | GO:0002111 | BRCA2-BRAF35 complex(GO:0002111) |
0.4 | 6.0 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.3 | 5.8 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.3 | 1.0 | GO:0097361 | CIA complex(GO:0097361) |
0.3 | 1.7 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.3 | 2.0 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.3 | 4.3 | GO:0034709 | methylosome(GO:0034709) |
0.3 | 1.6 | GO:0035841 | new growing cell tip(GO:0035841) |
0.3 | 4.7 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.3 | 0.9 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
0.3 | 11.7 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.3 | 3.4 | GO:0001940 | male pronucleus(GO:0001940) |
0.3 | 5.6 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.3 | 7.9 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.3 | 4.1 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.3 | 1.3 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.3 | 1.6 | GO:1903440 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
0.3 | 6.1 | GO:0043196 | varicosity(GO:0043196) |
0.2 | 4.4 | GO:0070852 | cell body fiber(GO:0070852) |
0.2 | 1.2 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.2 | 2.4 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.2 | 4.8 | GO:0061702 | inflammasome complex(GO:0061702) |
0.2 | 1.7 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.2 | 1.2 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.2 | 8.1 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.2 | 4.7 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.2 | 2.2 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.2 | 2.6 | GO:0048500 | signal recognition particle(GO:0048500) |
0.2 | 0.4 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
0.2 | 13.2 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.2 | 0.6 | GO:1902560 | GMP reductase complex(GO:1902560) |
0.2 | 6.6 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.2 | 2.9 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.2 | 0.8 | GO:0043259 | laminin-1 complex(GO:0005606) laminin-10 complex(GO:0043259) |
0.2 | 1.3 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
0.2 | 0.7 | GO:0043511 | inhibin complex(GO:0043511) |
0.2 | 3.4 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.2 | 0.9 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.2 | 3.5 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.2 | 10.5 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.2 | 0.7 | GO:0042584 | chromaffin granule membrane(GO:0042584) |
0.2 | 2.7 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.2 | 7.8 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.2 | 1.1 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.2 | 0.7 | GO:0045283 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.2 | 0.7 | GO:0035061 | interchromatin granule(GO:0035061) |
0.2 | 14.0 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.2 | 3.2 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.2 | 5.0 | GO:0099738 | cell cortex region(GO:0099738) |
0.2 | 1.3 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.2 | 3.5 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.2 | 2.5 | GO:0016342 | catenin complex(GO:0016342) |
0.2 | 4.5 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.2 | 2.0 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.2 | 2.4 | GO:0097470 | ribbon synapse(GO:0097470) |
0.2 | 29.5 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.1 | 1.0 | GO:0072487 | MSL complex(GO:0072487) |
0.1 | 1.5 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.1 | 1.6 | GO:0031931 | TORC1 complex(GO:0031931) |
0.1 | 0.6 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.1 | 0.4 | GO:0034455 | t-UTP complex(GO:0034455) |
0.1 | 1.8 | GO:1990635 | proximal dendrite(GO:1990635) |
0.1 | 0.5 | GO:0044308 | axonal spine(GO:0044308) |
0.1 | 3.9 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 0.4 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.1 | 1.6 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 3.4 | GO:0005839 | proteasome core complex(GO:0005839) |
0.1 | 1.4 | GO:0035102 | PRC1 complex(GO:0035102) |
0.1 | 0.5 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
0.1 | 0.5 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.1 | 0.6 | GO:0089701 | U2AF(GO:0089701) |
0.1 | 1.0 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.1 | 0.6 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.1 | 2.0 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 1.0 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.1 | 1.2 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.1 | 1.7 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 3.5 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.1 | 1.5 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.1 | 9.9 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 2.5 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.1 | 0.9 | GO:0005827 | polar microtubule(GO:0005827) |
0.1 | 0.7 | GO:0097342 | ripoptosome(GO:0097342) |
0.1 | 1.7 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.1 | 1.2 | GO:0000243 | commitment complex(GO:0000243) |
0.1 | 1.7 | GO:0051286 | cell tip(GO:0051286) |
0.1 | 13.2 | GO:0044291 | cell-cell contact zone(GO:0044291) |
0.1 | 2.1 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 0.5 | GO:0035363 | histone locus body(GO:0035363) |
0.1 | 3.3 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.1 | 47.0 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.1 | 1.2 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 1.4 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.1 | 0.3 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
0.1 | 0.7 | GO:0030689 | Noc complex(GO:0030689) |
0.1 | 1.5 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.1 | 1.1 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 3.3 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 6.2 | GO:0015934 | large ribosomal subunit(GO:0015934) |
0.1 | 8.1 | GO:0022626 | cytosolic ribosome(GO:0022626) |
0.1 | 3.9 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 35.5 | GO:0044429 | mitochondrial part(GO:0044429) |
0.1 | 0.3 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
0.1 | 3.0 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 0.2 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.1 | 7.1 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.1 | 2.5 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.1 | 8.7 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 2.5 | GO:0044215 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.1 | 1.2 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 0.3 | GO:0042827 | platelet dense granule membrane(GO:0031088) platelet dense granule(GO:0042827) |
0.1 | 0.5 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.1 | 1.7 | GO:0045120 | pronucleus(GO:0045120) |
0.1 | 0.6 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.1 | 106.3 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 1.8 | GO:0032040 | small-subunit processome(GO:0032040) |
0.1 | 2.3 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.1 | 5.1 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 4.7 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 3.6 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.1 | 2.2 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.1 | 1.4 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.1 | 0.2 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.1 | 0.3 | GO:0034684 | integrin alphav-beta5 complex(GO:0034684) |
0.1 | 0.8 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.1 | 0.3 | GO:0031417 | NatC complex(GO:0031417) |
0.1 | 1.4 | GO:0005605 | basal lamina(GO:0005605) |
0.1 | 2.6 | GO:0090544 | BAF-type complex(GO:0090544) |
0.1 | 0.4 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.1 | 10.6 | GO:0031674 | I band(GO:0031674) |
0.1 | 0.4 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 0.3 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.1 | 0.7 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.1 | 0.5 | GO:0042382 | paraspeckles(GO:0042382) |
0.1 | 3.3 | GO:0005657 | replication fork(GO:0005657) |
0.1 | 0.4 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 42.9 | GO:0016604 | nuclear body(GO:0016604) |
0.1 | 0.3 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.1 | 0.6 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.5 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 0.2 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.1 | 0.3 | GO:0000346 | transcription export complex(GO:0000346) |
0.1 | 20.8 | GO:0005925 | focal adhesion(GO:0005925) |
0.1 | 3.6 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.2 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.0 | 3.0 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 0.7 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.7 | GO:0031970 | organelle envelope lumen(GO:0031970) |
0.0 | 8.0 | GO:0043296 | apical junction complex(GO:0043296) |
0.0 | 1.0 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.0 | 0.1 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.0 | 0.2 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 0.2 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.0 | 1.2 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 6.8 | GO:0005770 | late endosome(GO:0005770) |
0.0 | 0.5 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 9.3 | GO:0000139 | Golgi membrane(GO:0000139) |
0.0 | 1.0 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.0 | 10.5 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 2.4 | GO:0055037 | recycling endosome(GO:0055037) |
0.0 | 2.8 | GO:0072686 | mitotic spindle(GO:0072686) |
0.0 | 0.9 | GO:0031901 | early endosome membrane(GO:0031901) |
0.0 | 0.3 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 0.7 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 0.3 | GO:1902562 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.0 | 0.8 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.0 | 0.9 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.0 | 31.5 | GO:0005654 | nucleoplasm(GO:0005654) |
0.0 | 1.3 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.1 | GO:0016011 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.0 | 0.5 | GO:0097440 | apical dendrite(GO:0097440) |
0.0 | 0.2 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 0.2 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
0.0 | 0.9 | GO:0042383 | sarcolemma(GO:0042383) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.5 | 13.8 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
3.4 | 10.1 | GO:0005287 | high-affinity basic amino acid transmembrane transporter activity(GO:0005287) high-affinity arginine transmembrane transporter activity(GO:0005289) high-affinity lysine transmembrane transporter activity(GO:0005292) |
2.8 | 11.4 | GO:0005008 | hepatocyte growth factor-activated receptor activity(GO:0005008) |
2.7 | 8.1 | GO:0004454 | ketohexokinase activity(GO:0004454) |
2.7 | 10.7 | GO:0005118 | sevenless binding(GO:0005118) |
2.6 | 7.8 | GO:0004372 | glycine hydroxymethyltransferase activity(GO:0004372) |
2.5 | 7.6 | GO:0008431 | vitamin E binding(GO:0008431) |
2.1 | 19.0 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
2.1 | 6.3 | GO:0004001 | adenosine kinase activity(GO:0004001) |
2.1 | 12.4 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
2.0 | 5.9 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
1.8 | 5.4 | GO:0001571 | non-tyrosine kinase fibroblast growth factor receptor activity(GO:0001571) |
1.8 | 5.3 | GO:0003826 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
1.4 | 7.2 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
1.4 | 7.2 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
1.4 | 11.4 | GO:1990190 | peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
1.4 | 4.3 | GO:0004326 | tetrahydrofolylpolyglutamate synthase activity(GO:0004326) |
1.4 | 4.2 | GO:0047291 | lactosylceramide alpha-2,3-sialyltransferase activity(GO:0047291) |
1.4 | 4.2 | GO:0016890 | site-specific endodeoxyribonuclease activity, specific for altered base(GO:0016890) |
1.4 | 4.2 | GO:0016296 | [acyl-carrier-protein] S-malonyltransferase activity(GO:0004314) oleoyl-[acyl-carrier-protein] hydrolase activity(GO:0004320) myristoyl-[acyl-carrier-protein] hydrolase activity(GO:0016295) palmitoyl-[acyl-carrier-protein] hydrolase activity(GO:0016296) acyl-[acyl-carrier-protein] hydrolase activity(GO:0016297) S-acetyltransferase activity(GO:0016418) S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) phosphopantetheine binding(GO:0031177) |
1.4 | 4.1 | GO:0004368 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
1.4 | 5.4 | GO:0004736 | pyruvate carboxylase activity(GO:0004736) |
1.3 | 3.8 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
1.2 | 3.6 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
1.1 | 3.3 | GO:0052870 | tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) |
1.1 | 4.3 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
1.0 | 4.2 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
1.0 | 2.1 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) |
1.0 | 3.1 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
1.0 | 4.1 | GO:0004329 | formate-tetrahydrofolate ligase activity(GO:0004329) |
1.0 | 3.0 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
1.0 | 3.0 | GO:0034632 | retinol transporter activity(GO:0034632) |
1.0 | 4.8 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.9 | 12.3 | GO:0000182 | rDNA binding(GO:0000182) |
0.9 | 11.0 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.9 | 2.7 | GO:0052692 | raffinose alpha-galactosidase activity(GO:0052692) |
0.9 | 6.3 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.9 | 3.6 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.9 | 5.3 | GO:0015232 | heme transporter activity(GO:0015232) |
0.9 | 3.4 | GO:0008176 | tRNA (guanine-N7-)-methyltransferase activity(GO:0008176) |
0.9 | 3.4 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
0.8 | 2.5 | GO:0000402 | open form four-way junction DNA binding(GO:0000401) crossed form four-way junction DNA binding(GO:0000402) |
0.8 | 3.4 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.8 | 0.8 | GO:0009383 | rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
0.8 | 5.7 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.8 | 4.9 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
0.8 | 2.4 | GO:0016898 | D-lactate dehydrogenase (cytochrome) activity(GO:0004458) oxidoreductase activity, acting on the CH-OH group of donors, cytochrome as acceptor(GO:0016898) |
0.8 | 4.0 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.8 | 3.2 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.8 | 2.4 | GO:0005333 | norepinephrine transmembrane transporter activity(GO:0005333) |
0.8 | 2.4 | GO:0036009 | protein-glutamine N-methyltransferase activity(GO:0036009) histone-glutamine methyltransferase activity(GO:1990259) |
0.8 | 4.6 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.7 | 9.7 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.7 | 4.4 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.7 | 2.2 | GO:0061711 | N(6)-L-threonylcarbamoyladenine synthase(GO:0061711) |
0.7 | 2.9 | GO:0030519 | snoRNP binding(GO:0030519) |
0.7 | 2.9 | GO:0098770 | FBXO family protein binding(GO:0098770) |
0.7 | 4.3 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.7 | 5.0 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.7 | 6.2 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.7 | 3.4 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.7 | 4.6 | GO:0097016 | L27 domain binding(GO:0097016) |
0.6 | 7.1 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) L-lactate dehydrogenase activity(GO:0004459) |
0.6 | 1.9 | GO:0047057 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
0.6 | 5.1 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.6 | 4.5 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.6 | 3.2 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.6 | 1.9 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
0.6 | 6.8 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.6 | 2.5 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
0.6 | 9.5 | GO:0031386 | protein tag(GO:0031386) |
0.6 | 3.0 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.6 | 28.0 | GO:0030332 | cyclin binding(GO:0030332) |
0.6 | 4.0 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.6 | 2.3 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.6 | 10.2 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.6 | 2.3 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.6 | 1.7 | GO:0019202 | glutamate 5-kinase activity(GO:0004349) glutamate-5-semialdehyde dehydrogenase activity(GO:0004350) delta1-pyrroline-5-carboxylate synthetase activity(GO:0017084) amino acid kinase activity(GO:0019202) |
0.5 | 9.7 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.5 | 4.3 | GO:0034452 | dynactin binding(GO:0034452) |
0.5 | 3.6 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
0.5 | 9.3 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.5 | 1.5 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.5 | 4.1 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.5 | 5.6 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.5 | 14.1 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.5 | 14.5 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.5 | 2.9 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
0.5 | 1.9 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.5 | 4.8 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.5 | 5.7 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.5 | 15.7 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.5 | 12.4 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.4 | 1.3 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.4 | 2.1 | GO:0004021 | L-alanine:2-oxoglutarate aminotransferase activity(GO:0004021) alanine-oxo-acid transaminase activity(GO:0047635) |
0.4 | 1.3 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.4 | 5.9 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.4 | 5.8 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.4 | 5.7 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.4 | 1.2 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
0.4 | 1.2 | GO:0015152 | glucose-6-phosphate transmembrane transporter activity(GO:0015152) |
0.4 | 3.3 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.4 | 2.8 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
0.4 | 4.4 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.4 | 1.6 | GO:0008515 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.4 | 1.2 | GO:0008480 | sarcosine dehydrogenase activity(GO:0008480) |
0.4 | 1.2 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
0.4 | 3.9 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.4 | 3.9 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.4 | 3.1 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.4 | 1.9 | GO:0055104 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
0.4 | 5.7 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.4 | 4.5 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.4 | 1.1 | GO:0004122 | cystathionine beta-synthase activity(GO:0004122) oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) nitrite reductase (NO-forming) activity(GO:0050421) carbon monoxide binding(GO:0070025) nitric oxide binding(GO:0070026) |
0.4 | 7.3 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.4 | 4.3 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.4 | 4.6 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.4 | 18.7 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.4 | 1.1 | GO:0032129 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
0.3 | 1.4 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.3 | 1.0 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.3 | 1.4 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.3 | 2.8 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.3 | 3.1 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.3 | 3.0 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.3 | 3.3 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.3 | 1.7 | GO:0004998 | transferrin receptor activity(GO:0004998) |
0.3 | 5.2 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.3 | 3.2 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.3 | 2.8 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.3 | 0.6 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
0.3 | 2.2 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
0.3 | 2.8 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.3 | 1.2 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.3 | 4.0 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.3 | 3.1 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.3 | 1.5 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.3 | 5.7 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.3 | 8.4 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.3 | 0.9 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
0.3 | 1.8 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.3 | 0.9 | GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
0.3 | 0.8 | GO:0033149 | FFAT motif binding(GO:0033149) |
0.3 | 1.1 | GO:0030627 | pre-mRNA 5'-splice site binding(GO:0030627) |
0.3 | 0.8 | GO:0033680 | ATP-dependent DNA/RNA helicase activity(GO:0033680) |
0.3 | 0.8 | GO:0004418 | hydroxymethylbilane synthase activity(GO:0004418) |
0.3 | 3.0 | GO:0046790 | virion binding(GO:0046790) |
0.3 | 7.6 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.3 | 1.6 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.3 | 1.6 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.3 | 2.4 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.3 | 0.5 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.3 | 1.6 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.3 | 1.0 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
0.3 | 1.6 | GO:0097643 | amylin receptor activity(GO:0097643) |
0.3 | 8.5 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.3 | 0.8 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.3 | 3.8 | GO:0031996 | thioesterase binding(GO:0031996) |
0.2 | 9.5 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.2 | 4.9 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.2 | 3.9 | GO:0005522 | profilin binding(GO:0005522) |
0.2 | 2.4 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.2 | 1.2 | GO:0070012 | oligopeptidase activity(GO:0070012) |
0.2 | 1.0 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.2 | 3.3 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.2 | 2.4 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.2 | 1.2 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.2 | 0.7 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) |
0.2 | 1.9 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.2 | 2.1 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.2 | 7.0 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.2 | 4.2 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.2 | 0.7 | GO:0016426 | tRNA (adenine) methyltransferase activity(GO:0016426) |
0.2 | 0.9 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.2 | 14.0 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.2 | 0.6 | GO:0016657 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
0.2 | 2.1 | GO:0043426 | MRF binding(GO:0043426) |
0.2 | 1.5 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.2 | 3.2 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
0.2 | 3.7 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.2 | 4.3 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.2 | 5.4 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.2 | 1.4 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.2 | 13.1 | GO:0015485 | cholesterol binding(GO:0015485) |
0.2 | 3.5 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.2 | 4.6 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.2 | 1.1 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.2 | 3.6 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.2 | 1.3 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.2 | 0.9 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.2 | 3.3 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.2 | 3.6 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
0.2 | 2.9 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.2 | 2.1 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.2 | 3.9 | GO:0010181 | FMN binding(GO:0010181) |
0.2 | 5.2 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
0.2 | 4.3 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.2 | 10.4 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.2 | 11.5 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.2 | 3.7 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.2 | 0.7 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.2 | 1.0 | GO:0003680 | AT DNA binding(GO:0003680) |
0.2 | 0.7 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.2 | 0.8 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.2 | 2.3 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
0.2 | 1.8 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.2 | 9.6 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.2 | 3.2 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.2 | 0.6 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
0.2 | 0.9 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.2 | 1.2 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.2 | 2.0 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.2 | 1.1 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.2 | 0.5 | GO:0004637 | phosphoribosylamine-glycine ligase activity(GO:0004637) |
0.2 | 0.9 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.2 | 0.6 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.2 | 2.0 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.2 | 3.2 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.1 | 1.8 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.1 | 2.2 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.1 | 1.5 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.1 | 0.4 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.1 | 0.6 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 0.6 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
0.1 | 1.0 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 0.4 | GO:0038100 | nodal binding(GO:0038100) |
0.1 | 0.9 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.1 | 2.3 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.1 | 8.8 | GO:0070888 | E-box binding(GO:0070888) |
0.1 | 1.8 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.1 | 5.1 | GO:0016879 | ligase activity, forming carbon-nitrogen bonds(GO:0016879) |
0.1 | 6.2 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.1 | 1.5 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.1 | 1.2 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.1 | 0.7 | GO:0034602 | oxoglutarate dehydrogenase (NAD+) activity(GO:0034602) |
0.1 | 0.4 | GO:0004615 | phosphomannomutase activity(GO:0004615) |
0.1 | 0.6 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.1 | 1.2 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.1 | 0.6 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.1 | 0.5 | GO:0004335 | galactokinase activity(GO:0004335) |
0.1 | 1.1 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.1 | 0.5 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.1 | 0.1 | GO:0050436 | microfibril binding(GO:0050436) |
0.1 | 2.3 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 1.1 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 0.8 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.1 | 2.1 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.1 | 1.3 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.1 | 5.3 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.1 | 3.6 | GO:0034061 | DNA-directed DNA polymerase activity(GO:0003887) DNA polymerase activity(GO:0034061) |
0.1 | 1.4 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.1 | 0.3 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.1 | 0.5 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.1 | 7.0 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 0.9 | GO:0042285 | xylosyltransferase activity(GO:0042285) |
0.1 | 0.5 | GO:0045183 | translation factor activity, non-nucleic acid binding(GO:0045183) |
0.1 | 0.9 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.1 | 6.5 | GO:0051287 | NAD binding(GO:0051287) |
0.1 | 0.3 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.1 | 1.2 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.1 | 0.3 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.1 | 0.4 | GO:0035575 | histone demethylase activity (H4-K20 specific)(GO:0035575) |
0.1 | 1.0 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.1 | 12.4 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.1 | 8.1 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 0.3 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.1 | 5.7 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.1 | 2.5 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 0.9 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.1 | 25.1 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
0.1 | 2.4 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.1 | 0.8 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.1 | 0.8 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.1 | 2.4 | GO:0030275 | LRR domain binding(GO:0030275) |
0.1 | 0.6 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.1 | 6.6 | GO:0005507 | copper ion binding(GO:0005507) |
0.1 | 41.7 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.1 | 3.4 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.1 | 0.7 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.1 | 0.8 | GO:0000987 | core promoter proximal region sequence-specific DNA binding(GO:0000987) |
0.1 | 0.4 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.1 | 0.8 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.1 | 5.8 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.1 | 14.9 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 1.3 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.1 | 3.8 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.1 | 0.3 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 0.4 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.1 | 1.7 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 1.6 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.1 | 1.1 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.1 | 0.2 | GO:0034046 | poly(G) binding(GO:0034046) |
0.1 | 14.3 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.1 | 1.0 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.1 | 2.6 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 1.6 | GO:0008143 | poly(A) binding(GO:0008143) |
0.1 | 1.7 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.1 | 1.5 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.1 | 0.9 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 0.2 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
0.1 | 2.9 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 0.3 | GO:0033797 | selenate reductase activity(GO:0033797) |
0.1 | 2.0 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.1 | 1.4 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.1 | 0.3 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.1 | 0.3 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.1 | 0.4 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.1 | 1.5 | GO:0019843 | rRNA binding(GO:0019843) |
0.1 | 0.2 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.1 | 0.4 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
0.1 | 0.4 | GO:0035198 | miRNA binding(GO:0035198) |
0.1 | 2.4 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 4.5 | GO:0004527 | exonuclease activity(GO:0004527) |
0.1 | 1.4 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.1 | 0.4 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.1 | 1.5 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.1 | 0.4 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 0.2 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.1 | 1.2 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.1 | 0.7 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.1 | 1.2 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.1 | 1.5 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 5.7 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.1 | 0.3 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 5.1 | GO:0017022 | myosin binding(GO:0017022) |
0.1 | 0.2 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.1 | 0.2 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.1 | 0.1 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.1 | 0.6 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 0.6 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.1 | 3.6 | GO:0043621 | protein self-association(GO:0043621) |
0.1 | 1.6 | GO:0000049 | tRNA binding(GO:0000049) |
0.1 | 1.3 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.1 | 0.7 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 0.6 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
0.0 | 0.5 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.0 | 4.8 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.0 | 0.7 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.0 | 0.5 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.0 | 0.5 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.0 | 0.8 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.0 | 0.2 | GO:0004921 | interleukin-11 receptor activity(GO:0004921) interleukin-11 binding(GO:0019970) |
0.0 | 0.7 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.0 | 0.3 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.0 | 0.4 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.0 | 0.5 | GO:1990405 | protein antigen binding(GO:1990405) |
0.0 | 1.7 | GO:0034062 | RNA polymerase activity(GO:0034062) |
0.0 | 2.0 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.0 | 1.1 | GO:0017166 | vinculin binding(GO:0017166) |
0.0 | 0.2 | GO:0008493 | tetracycline transporter activity(GO:0008493) |
0.0 | 1.2 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.0 | 0.4 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.0 | 5.3 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 0.2 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.0 | 0.3 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.0 | 0.8 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 0.3 | GO:0034711 | inhibin binding(GO:0034711) |
0.0 | 1.2 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
0.0 | 1.5 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.0 | 0.9 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.6 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.0 | 1.7 | GO:0016279 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
0.0 | 1.6 | GO:0043531 | ADP binding(GO:0043531) |
0.0 | 1.2 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.0 | 0.5 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.0 | 1.5 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.0 | 5.8 | GO:0043565 | sequence-specific DNA binding(GO:0043565) |
0.0 | 1.5 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.0 | 1.0 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.0 | 0.7 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.0 | 0.7 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.3 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.0 | 0.5 | GO:0001618 | virus receptor activity(GO:0001618) |
0.0 | 0.2 | GO:0048156 | tau protein binding(GO:0048156) |
0.0 | 0.9 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.0 | 0.3 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.0 | 15.3 | GO:0001071 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.0 | 0.2 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.0 | 0.9 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 0.5 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.0 | 0.6 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.0 | 0.3 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.0 | 0.5 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.0 | 0.4 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 0.1 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.0 | 0.8 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 1.8 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.0 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.0 | 0.1 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.0 | 0.1 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.0 | 0.5 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.0 | 0.1 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.0 | 0.5 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.2 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.0 | 0.1 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 26.6 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.7 | 2.6 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.6 | 11.0 | ST STAT3 PATHWAY | STAT3 Pathway |
0.5 | 67.0 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.4 | 8.7 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.3 | 15.0 | PID ARF6 PATHWAY | Arf6 signaling events |
0.3 | 4.5 | PID MYC PATHWAY | C-MYC pathway |
0.2 | 3.8 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.2 | 5.6 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.2 | 8.9 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.2 | 8.0 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.2 | 6.3 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.2 | 3.3 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.2 | 16.7 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.2 | 11.9 | PID RHOA PATHWAY | RhoA signaling pathway |
0.2 | 6.6 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.2 | 15.6 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.2 | 5.3 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.2 | 4.1 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.2 | 11.1 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.2 | 0.9 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.2 | 26.6 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.2 | 1.9 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.2 | 9.5 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.2 | 6.8 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.2 | 5.1 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 1.9 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.1 | 6.2 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 6.2 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 6.4 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 2.9 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 2.2 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 2.4 | PID IGF1 PATHWAY | IGF1 pathway |
0.1 | 0.7 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.1 | 6.5 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 2.9 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 6.3 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.1 | 0.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 3.8 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.1 | 6.1 | PID P73PATHWAY | p73 transcription factor network |
0.1 | 4.7 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 4.9 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.1 | 5.4 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 4.6 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.1 | 4.8 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 5.2 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.1 | 2.0 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 1.6 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 2.6 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.1 | 1.4 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 2.4 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 1.1 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 1.6 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 1.7 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 2.6 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 0.9 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 1.6 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 0.6 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.0 | 0.6 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 0.9 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 4.0 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 2.9 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 1.0 | PID FOXO PATHWAY | FoxO family signaling |
0.0 | 0.5 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 0.9 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 1.8 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.9 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 1.4 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.6 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 2.7 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.0 | 0.9 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 0.4 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.9 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.4 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.0 | 0.6 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.8 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.7 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 0.1 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.6 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.3 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 0.2 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.0 | 0.8 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.0 | 0.3 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.5 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 0.1 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.3 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 0.2 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 20.9 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.6 | 11.0 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.6 | 25.6 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.6 | 12.1 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.6 | 11.2 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.6 | 15.1 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.5 | 6.6 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.5 | 30.4 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.5 | 9.5 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.5 | 21.2 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.5 | 13.4 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.4 | 8.2 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.4 | 9.9 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.4 | 11.8 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.4 | 11.4 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.4 | 4.2 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.3 | 3.5 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.3 | 4.2 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.3 | 8.3 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.3 | 5.0 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.3 | 12.8 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.3 | 22.1 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.3 | 9.9 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.3 | 5.8 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.3 | 12.4 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.3 | 10.5 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.3 | 7.5 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.3 | 0.8 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.3 | 5.8 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.2 | 4.8 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.2 | 6.2 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.2 | 6.7 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.2 | 10.5 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.2 | 3.5 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.2 | 4.6 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.2 | 5.6 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.2 | 0.9 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.2 | 8.4 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.2 | 2.8 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.2 | 10.8 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.2 | 13.2 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.2 | 10.4 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.2 | 9.4 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.2 | 3.1 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.2 | 0.9 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.2 | 8.0 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.2 | 3.9 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.2 | 4.4 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.2 | 2.7 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.2 | 4.5 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.2 | 18.2 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.2 | 22.6 | REACTOME TRANSLATION | Genes involved in Translation |
0.2 | 3.2 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B | Genes involved in APC/C:Cdc20 mediated degradation of Cyclin B |
0.2 | 13.6 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.2 | 0.7 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.2 | 2.4 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.2 | 0.6 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.2 | 2.3 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.2 | 1.7 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 2.8 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 7.4 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 1.6 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.1 | 1.7 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 7.2 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 3.2 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.1 | 5.7 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.1 | 1.4 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 1.0 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.1 | 1.8 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.1 | 3.8 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.1 | 5.7 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 5.4 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 3.7 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.1 | 3.5 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 1.0 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.1 | 6.6 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 7.4 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 2.5 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.1 | 4.8 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 3.3 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 4.5 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 1.6 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.1 | 4.2 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 1.5 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.1 | 1.6 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 2.3 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.1 | 0.3 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.1 | 1.6 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.1 | 4.4 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.1 | 0.5 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.1 | 1.7 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.1 | 15.1 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.1 | 0.5 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 1.4 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.1 | 1.1 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.1 | 4.0 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 5.1 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.1 | 0.7 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.1 | 0.7 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.1 | 2.6 | REACTOME RNA POL III TRANSCRIPTION | Genes involved in RNA Polymerase III Transcription |
0.1 | 1.6 | REACTOME PI3K AKT ACTIVATION | Genes involved in PI3K/AKT activation |
0.1 | 1.1 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 1.5 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 0.7 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.1 | 2.1 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.1 | 0.5 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 3.5 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 1.2 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.1 | 2.4 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 1.6 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 0.9 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 1.0 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 1.6 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.1 | 1.2 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 0.6 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.1 | 0.3 | REACTOME G PROTEIN BETA GAMMA SIGNALLING | Genes involved in G-protein beta:gamma signalling |
0.0 | 0.5 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.0 | 0.0 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.0 | 0.1 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.0 | 0.8 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.0 | 0.2 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 0.7 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.0 | 1.5 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 1.0 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.0 | 6.5 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.0 | 5.1 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 0.6 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.0 | 0.7 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.0 | 1.2 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.0 | 0.3 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 2.1 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.0 | 0.9 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.0 | 1.3 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.0 | 0.6 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 1.4 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 0.6 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.0 | 0.5 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.0 | 0.2 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.0 | 0.2 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 0.9 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.0 | 1.1 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.0 | 0.2 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 0.1 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.0 | 0.9 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |